Prime Therapeutics’ Omaha office transitions to fully remote workforce

Changes made due to COVID-19 pandemic allows for long-term convenience, flexibility

April 13, 2021
EAGAN, Minn. – After successfully working from home for more than a year, Omaha employees at Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members nationally, will be remote working for the long-term. Omaha employees began working from home in March 2020 coinciding with Nebraska’s business flexibility recommendations.

According to an employee survey, this is a welcome decision to the majority of Prime’s Omaha workforce. Employees appreciate the added flexibility working from home provides, along with the ability to stay safe and healthy.

“When Prime was one of the first organizations to have employees work from home last March, we could not have predicted how well our staff would handle the change, but they have thrived,” said Dustin Cheek, vice president of operations at Prime. “While we will all miss seeing one another face-to-face in our state-of-the-art facility, our employees appreciate the added flexibility of being home while also feeling like they are being as – or more – productive as they were in the office. It’s the best of both worlds as Prime continues its commitment to employing workers in the Omaha area.”

The Omaha facility, located at 10802 Farnam Drive, held approximately 230 Prime staff members, mostly in contact center and clinical operations roles. This is in addition to nearly 90 Omaha-area employees who were previously working from home pre-pandemic. Prime will explore opportunities to sub-lease the newly renovated office building.

Related news

Press releases

June 2, 2022

Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy

EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed…

Press releases

May 23, 2022

Prime Therapeutics’ MedDrive™ program leverages biosimilars to cut member drug expenses by 26% in one year

EAGAN, Minn. –  Prime Therapeutics LLC (Prime) announced that its MedDrive™ program achieved…